Feasibility Study of Dynasplint to Prevent Trismus in Head and Neck Cancer
| Status: | Completed |
|---|---|
| Conditions: | Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 10/19/2013 |
| Start Date: | August 2012 |
| End Date: | July 2014 |
| Contact: | Lauren A Zatarain, MD |
| Phone: | 615-835-9443 |
A Feasibility Study to Evaluate Use of the Jaw Dynasplint System to Prevent Trismus in Patients With Head and Neck Cancer Receiving Primary or Adjuvant Radiation-Based Therapy
The purpose of this study is to see if use of a device called the Jaw Dynasplint® System can
be used during and immediately after cancer treatment. The Dynasplint® is a stretching
device that is used to treat joint stiffness and limited range of motion in the jaw. The
device is currently approved for treatment of trismus once it has developed. This study
will investigate the use of the device during and immediately after cancer treatment to
prevent trismus.
Data suggest that early intervention with mechanical stretching devices for head and neck
cancer patients undergoing curative therapy maximizes their effectiveness in the treatment
of trismus. That being said, treatment for trismus typically begins after head and neck
cancer patients are found to have moderate to severe reduction in jaw range of motion.
Typically, clinicians will begin therapy when the IID is 3.0 cm or less. A subset of head
and neck cancer patients will develop severe or rapidly progressive trismus that will fail
to respond to treatment. In this cohort, trismus may lead to permanent, severe morbidity. It
may be hypothesized that preventative strategies that encourage routine stretching during
and immediately after the completion of cancer therapy may prevent or minimize trismus. No
studies have examined the prophylactic use of the Jaw Dynasplint® System during cancer
treatment.
Furthermore, it is not known whether patients can tolerate wearing a mechanical stretching
device during treatment. The investigators would like to test the hypothesis that: 1)
preventive use of a mechanical stretching device during cancer treatment and early recovery
is feasible, and 2) preventive use of a mechanical stretching device will result in a marked
decrease in the incidence and severity of trismus in patients undergoing primary or adjuvant
radiation therapy for head and neck cancer.
Inclusion Criteria:
1. Patients with histologically proven head and neck cancer
2. Planned primary or adjuvant radiation treatment with 50cGy or greater delivered to a
total volume of at least 2cc to the muscles of mastication, unilaterally or
bilaterally, over the entire course of radiation treatment
3. Patients receiving induction or concurrent chemotherapy
4. Baseline interincisoral distance > 35 mm
5. Willing and able to provide informed consent
6. Sufficient manual dexterity to utilize the device
7. All participants must be at least 21 years of age
Exclusion Criteria:
1. Patients with collagen vascular disorders that may predispose to radiation fibrosis
2. Patients with oral health issues that would preclude use of the device as identified
during a pre-radiation dental evaluation
We found this trial at
1
site
Vanderbilt University Vanderbilt offers undergraduate programs in the liberal arts and sciences, engineering, music, education...
Click here to add this to my saved trials
